Considering the difference of the treatment and to explore whether this difference affected the modifying role of ARHGAP35 rs1052667 polymorphism, we stratified the analysis of the effects of ARHGAP35 genotypes on osteosarcoma outcome by the treatment status. This evidence concerns the gene ARHGAP35 and osteosarcoma.